BeStock  
Stocks › Medical Devices › GMED

Globus Medical GMED

US equityMarket cap rank #1513Medical Devices
$66.89 −$1.71 (-2.49%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $66.89 0.00%
Open$68.44
Prev close$68.60
Day range$66.63 – $69.54
Volume1.51M
Market cap$8.86B
P/E (TTM)16.5
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership96.6%+6.46 pts vs. prior quarter
Institutions holding721+19 vs. prior quarter
Insider trades (recent)28 buys / 21 sellsNet buying
Short interest7.04% of floatDays to cover 8.1 · as of 30 Oct 2026
Short-sale volume share20.9%5-day average of daily volume

Short-sale volume as % of daily volume

9%19%28%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$22.62M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$12.4MSuper−$10.2MBig−$2.9MMid+$405.8KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.8% of shares outstanding.

Largest holders

  • David Paul16.85%
  • BlackRock8.23%
  • Janus Henderson Group plc6.19%
  • Vanguard Capital Management, LLC3.83%
  • Vanguard Portfolio Management, LLC3.67%
  • Kayne Anderson Rudnick Investment Management, LLC3.23%
  • Invesco Ltd.3.07%
  • State Street Global Advisors2.81%

By investor type

  • Mutual Fund81.05%
  • Individual/Insider17.41%
  • Hedge Fund6.55%
  • Public Company4.21%
  • Government Pension Fund1.77%
  • Private Company1.07%
  • Sovereign Wealth Fund0.86%
  • Insurance Company0.59%

Reported short interest has risen from 5.07% to 7.04% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Swedbank Robur Fonder AB Mutual Fund 2026/Q3 +2,360,480 2.2%
Boston Partners Global Investors, Inc. Mutual Fund 2026/Q3 +1,860,564 2.6%
Morgan Stanley Public Company 2026/Q3 +1,093,085 1.7%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +1,093,085 1.7%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +638,132 2.3%
Allspring Global Investments, LLC Mutual Fund 2026/Q3 +225,534 1.4%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +208,000 0.3%
Public Sector Pension Investment Board Government Pension Fund 2026/Q3 +194,296 0.2%
Kayne Anderson Rudnick Investment Management, LLC Mutual Fund 2026/Q3 +4,279,730 3.2%
Boston Partners Global Investors, Inc. Mutual Fund 2026/Q3 +1,554,990 1.2%
Allspring Global Investments, LLC Mutual Fund 2026/Q3 +1,143,641 1.2%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q3 +803,716 1.3%
Quantinno Capital Management LP Mutual Fund 2026/Q3 +672,003 0.9%
Wells Fargo & Company Public Company 2026/Q3 +668,668 0.7%
AllianceBernstein Mutual Fund 2026/Q3 +629,512 1.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
9 Nov 2026 James Tobin Independent Director Derivative Exercise and Sale -41,666 $75.68 –
3 Nov 2026 Ann Rhoads Independent Director Automatic Disposition -5,000 $85.00 35,384
14 Sep 2026 James Tobin Independent Director Derivative Exercise and Sale -30,000 $74.58 –
17 Aug 2026 Stephen Zarrilli Independent Director Derivative Exercise and Sale -25,000 $87.04 –
26 Jul 2026 David Davidar Independent Director Other Disposition -2,500 – 673,642
4 Jun 2026 David Davidar Independent Director Derivative Exercise and Sale -25,000 $80.76 676,142
3 Jun 2026 Ann Rhoads Independent Director Derivative Exercise and Retained +25,000 $26.27 40,384
13 Apr 2026 John DeFord Former Independent Director Intent to Sell (Form 144) -30,000 $93.10 –
24 Feb 2026 Kelly Huller General Counsel Derivative Exercise and Sale -20,000 $94.50 –
11 Feb 2026 Kelly Huller General Counsel Derivative Exercise and Sale -10,000 $87.67 –
20 Jan 2026 Ann Rhoads Independent Director Other Derivative Acquisition +15,000 $94.15 15,000
20 Jan 2026 John DeFord Former Independent Director Other Derivative Acquisition +15,000 $94.15 15,000
20 Jan 2026 Stephen Zarrilli Independent Director Other Derivative Acquisition +15,000 $94.15 15,000
20 Jan 2026 James Tobin Independent Director Other Derivative Acquisition +15,000 $94.15 15,000
20 Jan 2026 David Paul Co-Founder & Executive Chairperson Other Derivative Acquisition +100,000 $94.15 100,000
20 Jan 2026 Daniel Wolterman Independent Director Other Derivative Acquisition +15,000 $94.15 15,000
20 Jan 2026 Robert Douglas Independent Director Other Derivative Acquisition +15,000 $94.15 15,000
20 Jan 2026 David Davidar Independent Director Other Derivative Acquisition +15,000 $94.15 15,000
20 Jan 2026 Leslie Norwalk Independent Director Other Derivative Acquisition +15,000 $94.15 15,000
20 Jan 2026 Daniel Lemaitre Independent Director Other Derivative Acquisition +15,000 $94.15 15,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 9,455,426 7.0% 8.1
15 Oct 2026 8,189,831 6.1% 5.5
30 Sep 2026 8,437,114 6.3% 5.1
15 Sep 2026 6,767,512 5.0% 4.6
31 Aug 2026 6,620,718 4.9% 6.5
14 Aug 2026 6,802,529 5.1% 4.0

Discussion

No comments yet — be the first to weigh in on GMED.

Sign in to join the discussion.

Scroll to Top